Aion Therapeutic Inc.
ANTCF
OTC PK
$0.0077
-$0.002-20.68%
Volume100
06/21/2022 1:34PM Eastern
Quotes delayed
01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | 01/31/2021 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -35.00K | 15.20K |
Gross Profit | -- | -- | -- | 35.00K | -15.20K |
SG&A Expenses | 226.70K | 332.60K | 310.00K | 811.90K | 344.40K |
Depreciation & Amortization | 13.80K | 18.40K | 18.80K | 18.40K | 19.30K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 240.50K | 351.00K | 328.80K | 795.30K | 378.90K |
Operating Income | -240.50K | -351.00K | -328.80K | -795.30K | -378.90K |
Income Before Tax | -513.90K | -637.80K | -607.80K | -4.18M | -1.24M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -513.90K | -637.80K | -607.80K | -4.18M | -1.24M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -513.90K | -637.80K | -607.80K | -4.18M | -1.24M |
EBIT | -240.50K | -351.00K | -328.80K | -795.30K | -378.90K |
EBITDA | -226.70K | -332.60K | -310.00K | -776.90K | -359.70K |
EPS Basic | 0.00 | 0.00 | 0.00 | -0.04 | -0.01 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | -0.04 | -0.01 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
Average Basic Shares Outstanding | 141.80M | 141.80M | 134.23M | 117.72M | 109.44M |
Average Diluted Shares Outstanding | 141.80M | 141.80M | 134.23M | 117.72M | 109.44M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |